Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/s41392-021-00822-x

http://scihub22266oqcxt.onion/10.1038/s41392-021-00822-x
suck pdf from google scholar
34916489!8674414!34916489
unlimited free pdf from europmc34916489    free
PDF from PMC    free
html from PMC    free
PDF vom PMID34916489 :   free

suck abstract from ncbi

pmid34916489
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors #MMPMID34916489
  • He X; Liu C; Peng J; Li Z; Li F; Wang J; Hu A; Peng M; Huang K; Fan D; Li N; Zhang F; Cai W; Tan X; Hu Z; Deng X; Li Y; Mo X; Li L; Shi Y; Yang L; Zhu Y; Wu Y; Liang H; Liao B; Hong W; He R; Li J; Guo P; Zhuo Y; Zhao L; Hu F; Li W; Zhu W; Zhang Z; Guo Z; Zhang W; Hong X; Cai W; Gu L; Du Z; Zhang Y; Xu J; Zuo T; Deng K; Yan L; Chen X; Chen S; Lei C
  • Signal Transduct Target Ther 2021[Dec]; 6 (1): 427 PMID34916489show ga
  • Abnormal glucose and lipid metabolism in COVID-19 patients were recently reported with unclear mechanism. In this study, we retrospectively investigated a cohort of COVID-19 patients without pre-existing metabolic-related diseases, and found new-onset insulin resistance, hyperglycemia, and decreased HDL-C in these patients. Mechanistically, SARS-CoV-2 infection increased the expression of RE1-silencing transcription factor (REST), which modulated the expression of secreted metabolic factors including myeloperoxidase, apelin, and myostatin at the transcriptional level, resulting in the perturbation of glucose and lipid metabolism. Furthermore, several lipids, including (+/-)5-HETE, (+/-)12-HETE, propionic acid, and isobutyric acid were identified as the potential biomarkers of COVID-19-induced metabolic dysregulation, especially in insulin resistance. Taken together, our study revealed insulin resistance as the direct cause of hyperglycemia upon COVID-19, and further illustrated the underlying mechanisms, providing potential therapeutic targets for COVID-19-induced metabolic complications.
  • |*Insulin Resistance[MESH]
  • |*Lipid Metabolism[MESH]
  • |Adult[MESH]
  • |Aged[MESH]
  • |Biomarkers/blood[MESH]
  • |COVID-19/*blood/complications[MESH]
  • |Female[MESH]
  • |Humans[MESH]
  • |Hyperglycemia/*blood/etiology[MESH]
  • |Lipids/*blood[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Retrospective Studies[MESH]
  • |SARS-CoV-2/*metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    427 1.6 2021